Documents from advisory groups on clinical-trial data
This page lists the documents from the advisory groups for the policy on proactive publication of clinical-trial data, which met between January and April 2013.
-
List item
CTAG1: Clinical Trial Advisory Group on protecting patient confidentiality - Membership overview (PDF/90.62 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG1: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on protecting patient confidentiality - Discussion Document (PDF/30.6 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG1: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on protecting patient confidentiality - Revised after first teleconference (PDF/305.59 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG1: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on protecting patient confidentiality - Revised after first teleconference with comments (PDF/110.9 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG1: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on protecting patient confidentiality - Revised after second teleconference with comments (PDF/124.89 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG1: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on protecting patient confidentiality - Revised after third teleconference with comments (PDF/201.83 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG1: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on protecting patient confidentiality - Final advice (PDF/50.87 KB)
First published: 30/04/2013
Last updated: 30/04/2013
-
List item
CTAG2: Clinical Trial Advisory Group on clinical-trial-data formats - Membership overview (PDF/101.11 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG2: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on clinical-trial-data formats – Initial text (PDF/25.27 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG2: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on clinical-trial-data formats - meeting 1 outcome with comments (PDF/264.22 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG2: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on clinical-trial-data formats - meeting 2 outcome with comments and amendments (PDF/239.04 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG2: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on clinical-trial-data formats – meeting 3 outcome with comments and amendments (PDF/92.65 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG2: Advice to the European Medicines Agency on Clinical Trial Advisory Group on clinical-trial-data formats - Final draft advice outcome with comments (PDF/136.64 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG2: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on clinical-trial-data formats - Final advice (PDF/74.16 KB)
First published: 30/04/2013
Last updated: 30/04/2013
-
List item
CTAG3: Clinical Trial Advisory Group on rules of engagement - Membership overview (PDF/105.46 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on rules of engagement - Initial discussion document (PDF/122.33 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on rules of engagement - Draft advice version 1.0 – including comments received on this version (PDF/271.44 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on rules of engagement - Draft advice version 5.0 – With amendments following comments on 1.0 (PDF/87.6 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on rules of engagement - Draft advice version 5.0 – Clean version (PDF/76.8 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency on rules of engagement for accessing clinical-trial data - Draft 5 March 2013 version 6.0 (PDF/265.14 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency on rules of engagement for accessing clinical-trial data - Draft 22 March 2013 version 7.0 (PDF/123.95 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency on rules of engagement for accessing clinical-trial data - Draft 22 March 2013 version 7.1 (PDF/164.83 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency on rules of engagement for accessing clinical-trial data - Draft 22 March 2013 version 7.2 (PDF/111.29 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency on rules of engagement for accessing clinical-trial data - Draft 4 April 2013 version 8.0 (PDF/123.88 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG3: Advice to the European Medicines Agency on rules of engagement for accessing clinical-trial data - Final advice 4 April 2013 version 9.0 (PDF/118.2 KB)
First published: 30/04/2013
Last updated: 30/04/2013
-
List item
CTAG4: Clinical Trial Advisory Group on good analysis practice - Membership overview (PDF/91.92 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG4: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on good analysis practice - Discussion document (PDF/45.39 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG4: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on good analysis practice - First draft with comments (PDF/438.6 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG4: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on good analysis practice - Second draft and comments (PDF/364.51 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG4: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on good analysis practice - Final advice (PDF/157.88 KB)
First published: 30/04/2013
Last updated: 30/04/2013
-
List item
CTAG5: Clinical Trial Advisory Group on legal aspects - Membership overview (PDF/81.73 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Initial text (PDF/59.12 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Meeting 1 summary overview (PDF/57.52 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Meeting 2 summary overview (PDF/66.63 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Meeting 1 and 2 comments submitted (PDF/224.3 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Draft advice (PDF/340.54 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Draft advice with comments and amendments (PDF/424.82 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Comments to draft final advice (PDF/226.15 KB)
First published: 30/04/2013
Last updated: 30/04/2013 -
List item
CTAG5: Advice to the European Medicines Agency from the Clinical Trial Advisory Group on legal aspects - Final advice (PDF/347.99 KB)
First published: 30/04/2013
Last updated: 30/04/2013